Plain-English translation of NCT07103382 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called attapulgite — a naturally occurring mineral clay — to see if it can help people with obesity or people who are overweight and have type 2 diabetes. Half of the participants will receive the actual medication as capsules, and half will receive a placebo (an inactive capsule that looks identical). The study lasts 12 weeks and will measure whether the treatment helps with weight loss and blood sugar control.
Current weight loss and diabetes medications have limited effectiveness or can cause side effects for some people. Researchers want to explore whether this medication, which works in the digestive system, might be a safe and effective new option for people struggling with obesity or diabetes.
You likely qualify if…
You likely don't qualify if…
You would take 3 capsules of either the medication or placebo twice daily for 12 weeks. You'll have regular visits where researchers measure your weight, blood sugar levels, and overall health to see if the treatment is working. The study will track whether you lose weight and whether your blood sugar improves, while also watching for any side effects.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
China
Sponsor
Second Xiangya Hospital of Central South University
Enrollment target
~40 participants
Started
June 2025
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated on clinicaltrials.gov in September 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.